| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = $3,571,656 ) |
| 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DC012564 | Usher Proteins in the Inner ear Structure and Function | 000 | 13 | NIH | 11/8/2024 | $569,580 |
| 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS129502 | Role of reactive astrocytes in prion diseases | 000 | 3 | NIH | 11/15/2024 | $560,291 |
| 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21HL172155 | Integration of Pharmacogenomics and Metabolomics in the Study of Antiplatelet Efficacy | 000 | 2 | NIH | 11/13/2024 | $116,625 |
| 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA285468 | First in Class Small molecules to simultaneously inhibit protein translation and an immune checkpoint in cancers | 000 | 2 | NIH | 11/15/2024 | $575,397 |
| 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21MD018107 | Identifying Structural Vulnerability Latent Classes Associated with the Health Outcomes of Latino Immigrant Men in Baltimore | 000 | 2 | NIH | 11/11/2024 | $186,303 |
| 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH129310 | Behavioral and neural mechanisms mediating social motivation in a rat model for ASD | 000 | 3 | NIH | 11/1/2024 | $436,018 |
| 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI168192 | Mechanisms coordinating the local and systemic resistance to pathogens | 000 | 3 | NIH | 10/30/2024 | $578,188 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1CA284883 | Baltimore CASCADE Study Site (BaCSS Project) | 000 | 2 | NIH | 11/14/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35GM144147 | Photonics-based Fluorescence Imaging for Research, Diagnostics, and Pathology | 000 | 3 | NIH | 11/7/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35GM140822 | Extracellular miRNAs, innate immunity, and critical illness | 000 | 4 | NIH | 11/15/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA284082 | Time-restricted eating to address cancer-related fatigue among survivors of hematological malignancies | 000 | 1 | NIH | 11/14/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21EB035168 | Elimination of slice alignment errors in 2-dimensional structural MRI | 000 | 1 | NIH | 11/14/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35DE030045 | Trigeminal nociceptors: Neural intersection of chronic pain and alveolar bone remodeling | 000 | 5 | NIH | 10/31/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35GM136225 | Mechanisms of BER in Genomic Integrity and Epigenetic Regulation | 000 | 5 | NIH | 11/7/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UH3HL143192 | Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE | 000 | 7 | NIH | 11/6/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R34AA032051 | External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting | 000 | 1 | NIH | 10/28/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35GM131710 | Macromolecular Conformational Heterogeneity | 000 | 6 | NIH | 11/4/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35GM148261 | Molecular mechanisms of proton-coupled dynamic processes in biology | 000 | 2 | NIH | 11/5/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL056051 | Fibrin(ogen) Structure and Interactions | 000 | 22 | NIH | 10/18/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS119609 | Nanocage-based systemic delivery of TGFb trap for immunomodulation of brain neoplasms | 002 | 4 | NIH | 10/21/2024 | $620,476 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA278939 | Longitudinal assessment of the role of interoception in chemotherapy-induced peripheral neuropathy (CIPN) along the cancer chemotherapy continuum | 000 | 1 | NIH | 10/25/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | P01MH139228 | Harnessing a Two-State FEP LHS to Optimize Engagement and Prevent Disengagement in CSC | 000 | 1 | NIH | 10/16/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | P01MH139228 | Harnessing a Two-State FEP LHS to Optimize Engagement and Prevent Disengagement in CSC | 001 | 1 | NIH | 11/11/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DA061324 | Peer Behavioral Activation Utilization to Address Structural Racism and Discrimination and Improve HIV Outcomes in High-Risk, Substance-Using Populations- PUSH | 000 | 1 | NIH | 10/10/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL155051 | Mechanisms of microvascular endothelial cell injury caused by extracellular histones | 000 | 4 | NIH | 10/17/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | NU58DP007088 | National Initiative to Advance Health Equity in K-12 Education by Preventing Chronic Disease and Promoting Healthy Behaviors: Priority 2-Emotional Well-Being | 01 | 3 | CDC | 10/18/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | H79SM082782 | Baltimore Network of Early Services Transformation (B-NEST) | 000 | 5 | SAMHSA | 10/8/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | H4B15526 | Poison Control Stabilization and Enhancement Program | 01 | 16 | HRSA | 10/21/2024 | $0 |
| 2025 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI143845 | IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection | 000 | 5 | NIH | 11/15/2024 | $0 |
| 2025 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI148166 | Role of Diabetes in MERS Coronavirus Pathogenesis | 000 | 4 | NIH | 11/7/2024 | $0 |
| 2025 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21CA259422 | Effects of exercise during platinum chemotherapy on neuropathy: examining the interoceptive brain system and inflammation | 000 | 2 | NIH | 10/25/2024 | $0 |
| 2025 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K99AR079558 | Mechanisms and impact of osteoblast "citration" on skeletal mineralization and global citrate homeostasis | 000 | 2 | NIH | 10/9/2024 | -$38,078 |
| 2025 | 2022 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K07CA225403 | Role of anal microbiota, local cytokines and HIV in persistence of high-risk human papillomavirus | 000 | 5 | NIH | 11/14/2024 | $0 |
| 2025 | 2022 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI140326 | Evolution of Adaptive Immunity | 000 | 29 | NIH | 10/29/2024 | $0 |
| 2025 | 2022 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21CA256314 | Synthetic Strategies to Restore the Efficacy of Venetoclax in Acute Myeloid Leukemia | 000 | 2 | NIH | 10/24/2024 | $0 |
| 2025 | 2022 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI158856 | Exploiting new drug targets in extremely resistant M.abscessus by using small molecule Lipid II binders | 000 | 2 | NIH | 10/29/2024 | $0 |
| 2025 | 2021 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U41HG008735 | The Disease Ontology Project: mechanistic profiles of human disease for biomedical and clinical research | 000 | 5 | NIH | 11/1/2024 | $0 |
| 2025 | 2020 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI125841 | Serological assays to predict Shigella vaccine efficacy | 000 | 5 | NIH | 11/6/2024 | $0 |
| 2025 | 2020 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL128492 | Prevention of Lung Transplant Injury with Adenosine 2A Receptor Agonis | 000 | 5 | NIH | 10/17/2024 | -$33,144 |
|
| Issue Date FY: 2024 ( Subtotal = $210,754,820 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01GM145806 | Molecular Physiology of Mitochondrial Calcium Uniporter | 000 | 2 | NIH | 4/19/2024 | $305,910 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K08HS028854 | Optimizing Implementation of Multiplex Molecular Panel Testing to Reduce Diagnostic Error | 000 | 3 | AHRQ | 6/21/2024 | $150,755 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01GM145806 | Molecular Physiology of Mitochondrial Calcium Uniporter | 001 | 2 | NIH | 6/10/2024 | $33,990 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | D43TW012274 | Integrated Networks of Scholars in Global Health Research Training (INSIGHT) | 001 | 3 | NIH | 7/11/2024 | $80,373 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS127986 | Aquaporin-4 regulation by NCX1 in post-ischemic brain swelling | 000 | 3 | NIH | 7/25/2024 | $374,663 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS125232 | Improving Brain Recovery Through Glycoengineering | 000 | 3 | NIH | 7/25/2024 | $491,857 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | T32NS063391 | Multidisciplinary Training Program in Neuroscience | 000 | 20 | NIH | 7/11/2024 | $70,695 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | T32NS063391 | Multidisciplinary Training Program in Neuroscience | 000 | 20 | NIH | 7/11/2024 | $87,637 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | T32NS063391 | Multidisciplinary Training Program in Neuroscience | 000 | 20 | NIH | 7/11/2024 | $23,594 |
|